about
The search for novel analgesics: targets and mechanismsTetrodotoxin, an Extremely Potent Marine Neurotoxin: Distribution, Toxicity, Origin and Therapeutical UsesStructure and function of μ-conotoxins, peptide-based sodium channel blockers with analgesic activityLocal knockdown of the NaV1.6 sodium channel reduces pain behaviors, sensory neuron excitability, and sympathetic sprouting in rat models of neuropathic pain.Topical Tetrodotoxin Attenuates Photophobia Induced by Corneal Injury in the Rat.Marked difference in saxitoxin and tetrodotoxin affinity for the human nociceptive voltage-gated sodium channel (Nav1.7) [corrected]Molecular dynamics of ion transport through the open conformation of a bacterial voltage-gated sodium channelKnockdown of sodium channel NaV1.6 blocks mechanical pain and abnormal bursting activity of afferent neurons in inflamed sensory ganglia.Upregulation of the sodium channel NaVβ4 subunit and its contributions to mechanical hypersensitivity and neuronal hyperexcitability in a rat model of radicular pain induced by local dorsal root ganglion inflammation.Marine-sourced anti-cancer and cancer pain control agents in clinical and late preclinical development.Recent progress in neuroactive marine natural products.Advances in targeting voltage-gated sodium channels with small molecules.The role of the dorsal root ganglion in the development of neuropathic pain.Animal toxins influence voltage-gated sodium channel function.Natural product and natural product derived drugs in clinical trials.Venom-based biotoxins as potential analgesics.The chemistry and biology of guanidine natural products.Current and Future Issues in the Development of Spinal Agents for the Management of Pain.Effects of Tetrodotoxin in Mouse Models of Visceral Pain.Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics.Guanidinium Toxins and Their Interactions with Voltage-Gated Sodium Ion Channels.µ-Conotoxins Modulating Sodium Currents in Pain Perception and Transmission: A Therapeutic Potential.Highly Functionalized Tricyclic Oxazinanones via Pairwise Oxidative Dearomatization and N-Hydroxycarbamate Dehydrogenation: Molecular Diversity Inspired by Tetrodotoxin.Biotechnological and Pharmacological Applications of Biotoxins and Other Bioactive Molecules from Dinoflagellates.Characteristics of evodiamine-exerted stimulatory effects on rat jejunal contractility.Synthesis of tetrodotoxin, a classic but still fascinating natural product.Tetrodotoxin attenuates isoproterenol-induced hypertrophy in H9c2 rat cardiac myocytes.Tetrodotoxin, a Candidate Drug for Nav1.1-Induced Mechanical Pain?Effect of Tetrodotoxin Pellets in a Rat Model of Postherpetic Neuralgia.Evaluation of Helically Coiled and Knitted Open Tubular Reactors for the Efficient Post-Column Determination of Tetrodotoxin by High-Performance Liquid ChromatographyAddressing the Issue of Tetrodotoxin Targeting
P2860
Q24288817-9BFA130C-B034-4D2E-99E3-0F9057C246D2Q26780441-C3FC95DA-984E-4900-A525-3ED1CE139356Q27021886-EEC9D881-4754-4A4B-B982-862756FDA85EQ35205500-A60521BD-0B27-449C-898C-E74E05CE7E47Q36331537-2DD0248C-3FF2-4490-A890-8BBD6E6F11A3Q36397948-FC616C1E-C0F5-45E2-B040-D88F5C9981BCQ36782090-AE97FD59-552D-4574-A3F6-C11CFB8A3C1DQ36977608-0E6311A7-204B-42FA-9B6F-EB5360F1098BQ37080784-78C0B66E-7126-44EA-92A1-742D0E71C146Q37566220-E106E2C1-3665-4D3C-8A0F-6EE4BDF6ED79Q37639029-5E9C1C2D-B197-43F0-B59B-D39B130CD7E3Q38040330-60A63BE0-8E22-4566-8EF6-B6B448AFEEDEQ38196886-5B3802D0-E81A-4A20-919D-92E9B89540E5Q38204930-521B2675-6ADA-4D89-AF6C-4DB130F825E3Q38247457-4E25EDD1-98BB-495D-B49F-B6BBB5126102Q38252442-2210C4BD-E9FC-4D5B-AF1D-CA7292DFD9B6Q38675089-98F5B1F8-E333-4271-8C01-7A4A3AC91567Q38727831-4C56776E-EE41-4BEB-875B-069BA4230F7EQ41045838-C3709B28-E5E4-4255-B62E-FBD874468FBEQ43075742-88333E85-09BD-4830-8B99-09E8185A0BEAQ43249870-39F72394-736D-44C3-B655-76A4221AFF5AQ45384168-71A0AA23-CD26-4478-8637-281FFF7A8772Q46314612-D156D989-BD02-4BC0-B8F4-B017ADA03EBAQ47231970-A4EFC497-4028-4A13-96C8-9D2B5683872DQ47831334-DF82BD1A-9778-4E81-BDFF-C4FD8D6A60EFQ48009818-D15F962D-90B7-4455-A657-C51DC1986E15Q48134116-B7E3202D-24D0-4691-B923-38DB3C995F9DQ53707237-6C6D16FA-034A-488D-9FEC-E34243488283Q55473795-ED9096BB-153A-406E-8888-F02E699965AFQ58130523-A5E804F2-EBFA-48CB-98F5-5633118B2399Q58692119-C64E73BD-A000-4201-AC33-FCDE662D777E
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Tetrodotoxin (TTX) as a therapeutic agent for pain.
@ast
Tetrodotoxin (TTX) as a therapeutic agent for pain.
@en
Tetrodotoxin
@nl
type
label
Tetrodotoxin (TTX) as a therapeutic agent for pain.
@ast
Tetrodotoxin (TTX) as a therapeutic agent for pain.
@en
Tetrodotoxin
@nl
prefLabel
Tetrodotoxin (TTX) as a therapeutic agent for pain.
@ast
Tetrodotoxin (TTX) as a therapeutic agent for pain.
@en
Tetrodotoxin
@nl
P2093
P2860
P921
P356
P1433
P1476
Tetrodotoxin (TTX) as a therapeutic agent for pain
@en
P2093
Cristina Sánchez-Fernández
Cruz Miguel Cendán
Enrique José Cobos
Francisco Rafael Nieto
Miguel Ángel Tejada
P2860
P304
P356
10.3390/MD10020281
P577
2012-01-31T00:00:00Z